Haploidy, diploidy and evolution of antifungal drug resistance in Saccharomyces cerevisiae

Genetics

Volumn 168, Issue 4, 2004, Pages 1915-1923

  Anderson, James B ^a   Sirjusingh, Caroline ^a   Ricker, Nicole ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANTIFUNGAL AGENT; FLUCONAZOLE;

ARTICLE; CONTROLLED STUDY; DIPLOIDY; DRUG RESISTANCE; FUNGAL GENE; FUNGAL GENETICS; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; HAPLOIDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PDR1 GENE; PDR3 GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; SACCHAROMYCES CEREVISIAE;

ANTIFUNGAL AGENTS; DIPLOIDY; DRUG RESISTANCE, FUNGAL; EVOLUTION; FLUCONAZOLE; GENETIC MARKERS; HAPLOIDY; MUTATION; SACCHAROMYCES CEREVISIAE; TIME FACTORS;

FUNGI; SACCHAROMYCES CEREVISIAE;

EID: 11244294685     PISSN: 00166731     EISSN: None     Source Type: Journal    
DOI: 10.1534/genetics.104.033266     Document Type: Article

References (16)

1. ANDERSON, J. B., C. SIRJUSINGH, A. B. PARSONS, C. BOONE, C. WICKENS et al., 2003 Mode of selection and experimental evolution of antifungal drug resistance in Saccharomyces cerevisiae. Genetics 163: 1287-1298.
2. BERMAN, J., and P. E. SUDBERY, 2002 Candida albicans: a molecular revolution built on lessons from budding yeast. Nat. Rev. Genet. 3: 918-930.
3. DODGSON, A. R., C. PUJOL, D. W. DENNING, D. R. SOLL and A. J. FOX, 2003 Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J. Clin. Microbiol. 41: 5709-5717.
4. FIDEL, JR., P. L., J. A. VAZQUEZ and J. D. SOBEL, 1999 Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 12: 80-96.
5. KOLACZKOWSKA, A., M. KOLACZKOWSKI, A. DELAHODDE and A. GOFFEAU, 2002 Functional dissection of Pdr1p, a regulator of multidrug resistance in Saccharomyces cerevisiae. Mol. Genet. Genomics 267: 96-106.
6. KONDRASHOV, A. S., 1993 Classification of hypotheses on the advantage of amphimixis. J. Hered. 84: 372-387.
7. KONDRASHOV, A. S., and J. F. CROW, 1991 Haploidy or diploidy: Which is better? Nature 351: 314-315.
8. LUPETTI, A., R. DANESI, M. CAMPA, M. DEL TACCA and S. KELLY, 2002 Molecular basis of resistance to azole antifungals. Trends Mol. Med. 8: 76-81.
9. NOURANI, A., M. WESOLOWSKI-LOUVEL, T. DELAVEAU, C. JACQ and A. DELAHODDE, 1997 Multiple-drug-resistance phenomenon in the yeast Saccharomyces cerevisiae: involvement of two hexose transporters. Mol. Cell. Biol. 17: 5453-5460.
10. ORR, H. A., and S. P. OTTO, 1994 Does diploidy increase the rate of adaptation? Genetics 136: 1475-1480.
11. PAQUIN, C., and J. ADAMS, 1983 Frequency of fixation of adaptive mutations is higher in evolving diploid than haploid yeast populations. Nature 302: 495-500.
12. SANGLARD, D., and F. C. ODDS, 2002 Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2: 73-85.
13. SANGLARD, D., F. ISCHER, D. CALABRESE, M. DE MICHELI and J. BILLE, 1998 Multiple resistance mechanisms to azole antifungals in yeast clinical isolates. Drug Resist. Updates 1: 255-265.
14. WAHL, L. M., and D. C. KRAKAUER, 2000 Models of experimental evolution: the role of genetic chance and selective necessity. Genetics 156: 1437-1448.
15. WHITE, T. C., K. A. MARR and R. A. BOWDEN, 1998 Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11: 382-402.
16. ZEYL, C., T. VANDERFORD and M. CARTER, 2003 An evolutionary advantage of haploidy in large yeast populations. Science 299: 555-558.